Bharat Biotech on Monday utilized for emergency use authorisation for its indigenously developed COVID-19 vaccine ‘Covaxin’ to Medicine Controller Basic of India (DCGI), officers mentioned. Bharat Biotech is the third firm which has utilized for emergency use authorisation for its vaccine. It’s the second Indian firm to use for emergency use authorisation after the Serum Institute of India utilized for such use for a vaccine developed by Oxford College and AstraZeneca. Pfizer had utilized for the emergency use authorisation to DCGI on December 6.
More Stories
Dr Reddy’s inks licensing pact with Eli Lilly for COVID-19 therapy drug
Modi Naturals to launch sub-brand Oleev Kitchen to enter RTC/E segments as shoppers proceed to stay indoors
Centre points advisory on administration of Mucormycosis fungal an infection in COVID-19 sufferers